How is NuTec different from other clinical tests?

NuTEC is envisioned as a single device diagnosing many diseases as opposed to many individual tests in the hospital each diagnosing a single disease.

How do NuTec signatures work differently from individual tests?

The two are not mutually exclusive. Signatures allow you to ask the open-ended and unbiased question: ‘Is there a problem?’ However, if you have a specific question such as ‘Do I have diabetes mellitus?’ a specific test for glucose levels would make more sense.

Does NuTec detect DNA, RNA, proteins or small molecules?

NuTec is unbiased and reacts with all 4 classes. The resulting spots on the NuTec are not DNA, RNA, proteins and small molecules but rather the colorimetric products of these chemical reactions.

How is the NuTec signature generated?

A mixture of molecules in a sample applied to the NuTec undergoes chemical reactions upon heating which then result in a visual pattern of dark and light spots. By design, each spot on the NuTec reacts differently with the sample molecules. Physicochemical diversity among the spots is important for NuTec to search through a large enough chemical space in the sample. This diversity is the basis for generating the spot pattern.

What is the NuTec signature?

The NuTec signature is analogous to a hash function. A hash function takes information of arbitrary length (e.g. a large image file) and generates an output signature with a drastically smaller length (e.g. a string of 32 characters). The NuTec is the chemical version of a hash function. Just like a hash function, NuTec takes dimensionally large chemical information in a sample and reduces it to a chemical hash of X defined spots. Hash signatures are a great way of telling if a file downloaded off the internet matches the original. In the same way, Entopsis will be matching your chemical hash signature to a database of pre-validated hashes.

Are there other current approaches using signatures and how is NuTec different?

What sets NuTec apart from other platforms is the chemical hash concept. Chemical hashing does several things. It transforms chemical information into colorimetric information which can be acquired by a scanner or phone camera. It lets NuTec survey a chemical space which is unimaginably complex. The resulting hash signature is compact and easily amenable to database storage and template matching.

From our blog

Entopsis discussed in Miami Herald article

The Miami Herald just published an article about the relatively new healthcare startup economy in South Florida. Conventional wisdom motivates many healthcare startups to establish themselves in Boston and San Francisco. We at Entopsis are early to the game in Miami. Consider that Miami and its surrounding neighborhoods have a robust culture of disruption and improvisation. Here, being MacGyver is not a special skill. It’s a common survival trait hardwired by experience. Who has caught on to this fact? Not just smart investors like Krillion Ventures and G3 Capital but also international investors. The Floridan winds have brought hungry MacGyvers and smart capital together to create the perfect storm and we

Entopsis discussed in Miami Herald article

Entopsis presents at MedCity Conference


Our dashing CFO, Dr. George Huang (see left), presents today at the CONVERGE Conference in Philadelphia! This conference is highly relevant because of the diverse representation of decision makers present, including insurers, startups, regulators, pharmaceuticals, hospital administrators and more. It’s rare to have such a broad spectrum of med tech related expertise in one place.

Entopsis presents at MedCity Conference

Entopsis works with Bascom Palmer Faculty on Eye Microbiome Research

Entopsis is proud to support Dr. Kara Cavuoto’s research aimed at better understanding the microbiome of the pediatric eye.

The goal of our collaboration is to define the composition of the ocular surface microbial flora in children using novel culture-independent methods. Our hypothesis is that the microbiome of the ocular surface evolves with age. Additionally, we hypothesize that disruption of the normal ocular surface microbial community via antibiotics or other ocular therapies predisposes the eye to infection and disease. With the results of our pilot study, we will be able to create an ocular surface microbiome profile which would

Entopsis works with Bascom Palmer Faculty on Eye Microbiome Research